Antibody-mediated immunity against tuberculosis: Implications for vaccine development

Jacqueline M. Achkar, Arturo Casadevall

Research output: Contribution to journalArticle

Abstract

There is an urgent need for new and better vaccines against tuberculosis (TB). Current vaccine design strategies are generally focused on the enhancement of cell-mediated immunity. Antibody-based approaches are not being considered, mostly due to the paradigm that humoral immunity plays little role in the protection against intracellular pathogens. Here, we reappraise and update the increasing evidence for antibody-mediated immunity against Mycobacterium tuberculosis, discuss the complexity of antibody responses to mycobacteria, and address mechanism of protection. Based on these findings and discussions, we challenge the common belief that immunity against M. tuberculosis relies solely on cellular defense mechanisms, and posit that induction of antibody-mediated immunity should be included in TB vaccine development strategies.

Original languageEnglish (US)
Pages (from-to)250-262
Number of pages13
JournalCell Host and Microbe
Volume13
Issue number3
DOIs
StatePublished - Mar 13 2013
Externally publishedYes

Fingerprint

Tuberculosis Vaccines
Immunity
Mycobacterium tuberculosis
Antibodies
Mycobacterium
Humoral Immunity
Cellular Immunity
Antibody Formation
Vaccines

ASJC Scopus subject areas

  • Immunology and Microbiology(all)
  • Cancer Research
  • Molecular Biology

Cite this

Antibody-mediated immunity against tuberculosis : Implications for vaccine development. / Achkar, Jacqueline M.; Casadevall, Arturo.

In: Cell Host and Microbe, Vol. 13, No. 3, 13.03.2013, p. 250-262.

Research output: Contribution to journalArticle

@article{b1ae60350cea4d71b53adab3b5580a88,
title = "Antibody-mediated immunity against tuberculosis: Implications for vaccine development",
abstract = "There is an urgent need for new and better vaccines against tuberculosis (TB). Current vaccine design strategies are generally focused on the enhancement of cell-mediated immunity. Antibody-based approaches are not being considered, mostly due to the paradigm that humoral immunity plays little role in the protection against intracellular pathogens. Here, we reappraise and update the increasing evidence for antibody-mediated immunity against Mycobacterium tuberculosis, discuss the complexity of antibody responses to mycobacteria, and address mechanism of protection. Based on these findings and discussions, we challenge the common belief that immunity against M. tuberculosis relies solely on cellular defense mechanisms, and posit that induction of antibody-mediated immunity should be included in TB vaccine development strategies.",
author = "Achkar, {Jacqueline M.} and Arturo Casadevall",
year = "2013",
month = "3",
day = "13",
doi = "10.1016/j.chom.2013.02.009",
language = "English (US)",
volume = "13",
pages = "250--262",
journal = "Cell Host and Microbe",
issn = "1931-3128",
publisher = "Cell Press",
number = "3",

}

TY - JOUR

T1 - Antibody-mediated immunity against tuberculosis

T2 - Implications for vaccine development

AU - Achkar, Jacqueline M.

AU - Casadevall, Arturo

PY - 2013/3/13

Y1 - 2013/3/13

N2 - There is an urgent need for new and better vaccines against tuberculosis (TB). Current vaccine design strategies are generally focused on the enhancement of cell-mediated immunity. Antibody-based approaches are not being considered, mostly due to the paradigm that humoral immunity plays little role in the protection against intracellular pathogens. Here, we reappraise and update the increasing evidence for antibody-mediated immunity against Mycobacterium tuberculosis, discuss the complexity of antibody responses to mycobacteria, and address mechanism of protection. Based on these findings and discussions, we challenge the common belief that immunity against M. tuberculosis relies solely on cellular defense mechanisms, and posit that induction of antibody-mediated immunity should be included in TB vaccine development strategies.

AB - There is an urgent need for new and better vaccines against tuberculosis (TB). Current vaccine design strategies are generally focused on the enhancement of cell-mediated immunity. Antibody-based approaches are not being considered, mostly due to the paradigm that humoral immunity plays little role in the protection against intracellular pathogens. Here, we reappraise and update the increasing evidence for antibody-mediated immunity against Mycobacterium tuberculosis, discuss the complexity of antibody responses to mycobacteria, and address mechanism of protection. Based on these findings and discussions, we challenge the common belief that immunity against M. tuberculosis relies solely on cellular defense mechanisms, and posit that induction of antibody-mediated immunity should be included in TB vaccine development strategies.

UR - http://www.scopus.com/inward/record.url?scp=84875141413&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875141413&partnerID=8YFLogxK

U2 - 10.1016/j.chom.2013.02.009

DO - 10.1016/j.chom.2013.02.009

M3 - Article

C2 - 23498951

AN - SCOPUS:84875141413

VL - 13

SP - 250

EP - 262

JO - Cell Host and Microbe

JF - Cell Host and Microbe

SN - 1931-3128

IS - 3

ER -